Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Mikio Kamimura,1 Shigeharu Uchiyama,2 Yukio Nakamura,2,3 Shota Ikegami,2 Keijiro Mukaiyama,2 Hiroyuki Kato2 1Center for Osteoporosis and Spinal Disorders, Kamimura Orthopaedic Clinic, Matsumoto, Japan; 2Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan; 3Dep...

Full description

Bibliographic Details
Main Authors: Kamimura M, Uchiyama S, Nakamura Y, Ikegami S, Mukaiyama K, Kato H
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Minodronate
Risedronate
25(OH) vitamin D3
parathyroid hormone
pentosidine
Online Access:https://www.dovepress.com/short-term-bisphosphonate-treatment-reduces-serum-25oh-vitamin-d3-and--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/short-term-bisphosphonate-treatment-reduces-serum-25oh-vitamin-d3-and--peer-reviewed-article-TCRM

Similar Items